Polymeric micelle drug carrier systems: PEG-PAsp(Dox) and second generation of micellar drugs

Advances in Experimental Medicine and Biology

Volumn 519, Issue , 2003, Pages 155-177

  Nishiyama, Nobuhiro ^a   Kataoka, Kazunori ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 [4 DEOXY 4 (2,4 TETRADECADIENOYLGLYCYLAMINO) GLYCERO BETA MANNOHEPTOPYRANOSYLAMINO] 9H PURINE; CISPLATIN; DOXORUBICIN; DRUG CARRIER; GELDANAMYCIN; MACROGOL; PHOTOSENSITIZING AGENT; POLYASPARTIC ACID; POLYGLUTAMIC ACID; POLYLACTIDE; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN;

CONFERENCE PAPER; CONTROLLED DRUG RELEASE; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; HUMAN; HYDROPHOBICITY; MACROMOLECULE; MICELLE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CHEMISTRY, PHYSICAL; CISPLATIN; DOXORUBICIN; DRUG CARRIERS; HUMANS; MICELLES; NEOPLASMS; PEPTIDES; PHOTOCHEMOTHERAPY; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION;

EID: 0038294621     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (109)

1. Kataoka, K., Kwon, G. S., Yokoyama, M., Okano, T., Sakurai, Y., 1993, Block copolymer micelles as vehicles for drug delivery. J. Contr. Rel. 24: 119-132.
2. Kataoka, K., Harada, A., Nagasaki, Y., 2001, Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 47: 113-131.
3. Kabanov, A., Batrakova, E. V., Melik-Nubarov, N. S., Fedoseev, N. A., Dorodnich, T. Y., Alakhov, V. Y., Chekhonin, V. P., Nazarova, I. R., Kabanov, V. A., 1992, A new class of drug carders: micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain. J. Contr. Rel. 22: 141-158.
4. Allen, C., Maysinger, D., Eisenberg, A., 1999, Nano-engineering block copolymer aggregates for drug delivery. Colloids and Surfaces B: Biointerfaces 16: 3-27.
5. Lavasanifar, A., Sanuel, J., Kwon, G. S., 2002, Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. Adv. Drug Deliv. Rev. 54: 169-190.
6. Torchilin, V. P., 2002, PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv. Drug Deliv. Rev. 54: 235-252.
7. Kwon, G. S., Kataoka, K., 1995, Block copolymer micelles as long-circulating drug vehicles. Adv. Drug Deliv. Rev. 16: 295-309.
8. Yokoyama, M., Okano, T., Sakurai, Y., Fukushima, S., Okamoto, K., Kataoka, K., 1999, Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. J. Drug Targeting 7: 171-186.
9. Nishiyama, N., Kato, Y., Sugiyama, Y., Kataoka, K., 2001, Cisplatin-loaded polymermetal complex micelle with time-modulated decaying property as a novel drug delivery system. Pharm. Res. 18: 1035-1041.
10. Weissig, V., Whiteman, K. R., Torchilin, V. P., 1998, Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis Lung Carcinoma. Pharm. Res. 15: 1552-1556.
11. Scholz, C., Iijima, M., Nagasaki, Y., Kataoka, K., 1995, A novel reactive polymeric micelle. Polymeric micelle with aldehyde groups on its surface. Macromolecules 28: 7295-7297.
12. Nagasaki, Y., Okada, T., Scholz, C., Iijima, M., Kato, M., Kataoka, K., 1998, The reactive polymeric micelle based on an aldehyde-ended poly(ethylene glycol)-poly(lactide) block copolymer. Macromolecules 31: 1473-1479.
13. Yasugi, K., Nakamura, T., Nagasaki, Y., Kato, M., Kataoka, K., 1999, Sugar-installed polymer micelles: synthesis and micellization of poly(ethylene glycol)-poly(D,L-lactide) block copolymers having sugar groups at the PEG chain end. Macromolecules 32: 8024-8032.
14. Cammas, S. M., Okano, T., Kataoka, K., 1999, Functional and site-specific macromolecular micelles as high potential drug carriers. Colloids and Surfaces B: Biointerfaces 16: 207-215.
15. Kohori, F., Sakai, K., Aoyagi, T., Yokoyama, M., Sakurai, Y., Okano, T., 1998, Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-DL-lactide). J. Contr. Rel. 55: 87-98.
16. Chung J. E., Yokoyama, M., Okano, T., 2000, Inner core segment design for drug delivery control of thermo-responsive polymeric micelles. J. Contr. Rel. 65: 93-103.
17. Cammas, S., Suzuki, K., Sone, C., Sakurai, Y., Kataoka, K., Okano, T., 1997, Thermoresponsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers. J. Contr. Rel. 48: 157-164.
18. Kakizawa, Y., Harada, A., Kataoka, K., 1999, Environment-sensitive stabilization of core-shell structured polyion complex micelle by reversible cross-linking of the core through disulfide bond. J. Am. Chem. Soc. 121: 11247-11248.
19. Taillefer, J., Brasseur, N., van Lier, J. E., Lenaerts, V., Le Garrec, D., Leroux, J.-C., 2001, In-vitro and in-vivo evaluation of pH-sensitive polymeric micelles in a photodynamic cancer therapy model. J. Pharm. Pharmacol. 53: 155-156.
20. Kataoka, K., 1996, Targetable polymeric drugs, chapter 4 in "Controlled drug delivery: the next generation (K. Park, ed.), American Chemical Society, Washington D.C..
21. Matsumura, Y., Maeda, H., 1986, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs. Cancer Res. 46: 6387-6392.
22. Maeda, H., Matsumura, Y., 1989, Tumoritropic and lymphotropic principles of macromolecular drugs. Critical Rev. in Ther. Drug Carrier Syst. 6: 193-210.
23. Noguchi, Y., Wu, J., Duncan, R., Steohalm, J., Ulbrich, K., Akaike, T., Maeda, H., 1998, Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn. J. Cancer Res. 89: 307-314.
24. w) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. J. Biomed. Mater. Res. 21: 1341-1358.
25. Stolnik, S., Illum, L., Davis, S. S., 1995, Long circulating microparticulate drug carriers. Adv. Drug Del. Rev. 16: 195-214.
26. Mosqueria, V. C. F., Legrand, P., Gulik, A., Bourdon, O., Gref, R., Labarre, D., Barratt, G., 2001, Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanoparticles. Biomaterials 22: 2967-2979.
27. Harris, J. M., 1992, Introduction to biotechnical and biomedical applications for poly(ethylene glycol), in Poly(ethylene glycol) chemistry (J. M. Harris ed.), Plenum Press, New York.
28. Jeon, S. I., Lee, J. H., Andrade, J. D., De Gennes, P. G., 1991, Protein-surface interactions in the presence of polyethylene oxide. I. Simplified theory. J. Colloid Interface Sci. 142: 149-158.
29. Maeda, H., Sawa, T., Konno, T., 2001, Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Contr. Rel. 74: 47-61.
30. Dvorak, H. F., Brown, L. F., Detmar, M., Dvorak, A. M., 1995, Vascular permeability factor / vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146: 1029-1039.
31. Hobbs, S.K, Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., Jain, R. K., 1998, Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA 95: 4607-4612.
32. Jain, R. K., 2001, Delivery of molecular and cellular medicine to solid tumors. Adv. Drug Deliv. Rev. 46: 149-168.
33. Maeda, H., 2001, The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41: 189-207.
34. Maeda, H., Noguchi, Y., Sato, K., Akaike, T., 1994, Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn. J. Cancer Res. 85: 331-334.
35. Wu, J., Akaike, T., Maeda, H., 1998, Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger. Cancer Res. 58: 159-165.
36. Wu, J., Akaike, T., Hayashida, K., Okamoto, T., Okuyama, A., Maeda, H., 2001, Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases. Jpn. J. Cnacer. Res. 92: 439-451.
37. Kwon, G. S., Naito, M., Yokoyama, M., Okano, T., Sakurai, Y., Kataoka, K., 1993, Micelles based on AB block copolymers of poly(ethylene oxide) and poly(β-benzyl L-aspartate). Langmuir 9: 945-949.
38. Kataoka, K., Matsumoto, T., Yokoyama, M., Okano, T., Sakurai, Y., Fukushima, S., Okamoto, K., Kwon, G. S., 2000, Doxorubicin-loaded poly(ethylene oxide) and poly(β-benzyl L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J. Contr. Rel. 64: 143-153.
39. Yamamoto, Y., Nagasaki, Y., Kato, Y., Sugiyama, Y., Kataoka, K., 2001, Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge. J. Contr. Rel. 77: 27-38.
40. Yamamoto, Y., Nagasaki, Y., Kato, M., Kataoka, K., 1999, Surface modification of poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles: conjugation of charged peptide. Colloids and Surfaces B: Biointerfaces 16: 135-146
41. Verrechia, T., Spenlehauer, G., Bazile, D. V., Murry-Brelier, A., Archimbaud, Y., Veillard, M., 1995, Non-stealth (poly(lactic acid/ albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. J. Contr. Rel. 36: 49-61.
42. Bazile, D., Prudhomme, C., Bassoullet, M. T., Marlard, M., Spenlehauer, G., Veillard, M., 1995, Stealth Me-PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci. 84: 493-498.
43. Nakada, Y., Tudomi, R., Sakurai, K., Takahashi, Y., 1998, Evaluation of long-circulating nanoparticles using biodegradable ABA triblock copolymers containing of poly(L-lactic acid) A-blocks attached to central poly(oxyethylene) B-blocks in vivo. Int. J. Pharm. 175: 109-117.
44. Burt, H. M., Zhang, X., Toleikis, P., Embree, L., Hunter, W. L., 1999, Development of copolymers of poly(D,L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Colloids and Surfaces B: Biointerfaces 16: 161-171.
45. Allen, T. M., Hansen, C., 1991, Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim. Biophys. Acta 1068: 133-141.
46. Woodle, M. C., Matthay, K. K., Newman, M. S., Hidayat, J. E., Collins, L. R., Redemann, C., Martin, F. J., Papahadjopoulos, D., 1992, Versatility in lipid composition showing prolonged circulation with sterically stabilized liposome. Biochim. Biophys. Acta 1105: 193-200.
47. Takakura, Y., Fujita, T., Hashida, M., Sezaki, H., 1990, Distribution characteristics of macromolecules in tumor-bearing mice. Pharm. Res. 7: 339-346.
48. Y. Takakura, Hashida, M., 1996, Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution. Pharm. Res. 13: 820-831.
49. Nagasaki, Y., Yasugi, K., Yamamoto, Y., Harada, A., Kataoka, K., 2001, Sugar-installed block copolymer micelles: their preparation and specific interaction with lectin molecules. Biomacromolecules 2: 1067-1070.
50. Yokoyama, M., Okano, T., Sakurai, Y., Ekimoto, H., Shibazaki, C., Kataoka, K., 1991, Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 51: 3229-3236.
51. Yokoyama, M., Okano, T., Sakurai, Y., Kataoka, K., 1994, Improved synthesis of adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin. J. Contr. Rel. 32: 269-277.
52. Fukushima, S., Machida, M., Akutsu, T., Shimizu, K., Tanaka, S., Okamoto, K., Machida, H., Yokoyama, M., Okano, T., Sakurai, Y., Kataoka, K., 1999, Roles of adriamycin and adriamycin dimer in antitumor activity of the polymeric micelle carrier system, Colloids and Surfaces B: Biointerfaces 16: 227-236.
53. Yokoyama, M., Sugiyama, T., Okano, T., Sakurai, Y., Naito, M., Kataoka, K., 1993, Analysis of micelle formation of an adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer by gel permeation chromatography. Pharm. Res. 10: 895-899.
54. Yokoyama, M., Sugiyama, T., Okano, T., Sakurai, Y., Naito, M., Kataoka, K., 1993, Analysis of micelle formation of an adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer by gel permeation chromatography. Pharm. Res. 10: 895-899.
55. Kwon, G. S., Naito, M., Kataoka, K., Yokoyama, M., Sakurai, Y., Okano, T., 1994, Block copolymer micelles as vehicles for hydrophobic drugs. Colloids and Surfaces B: Biointerfaces 2: 429-434.
56. Kwon, G. S., Naito, M., Yokoyama, M., Okano, T., Sakurai, Y., Kataoka, K., 1995, Physical entrapment of adriamycin in AB block copolymer micelles. Pharm. Res. 12: 192-195.
57. Kwon, G. S., Naito, M., Yokoyama, M., Okano, T., Sakurai, Y., Kataoka, K., 1997, Block copolymer micelles for drug delivery: loading and release of doxorubicin. J. Contr. Rel. 48: 195-201.
58. La, S. B., Okano, T., Kataoka, K., 1996, Preparation and characterization of the micelleforming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(β-benzyl L-aspartate) block copolymer micelles. J. Pharm. Sci. 85: 85-90.
59. Liaw, J., Aoyagi, T., Kataoka, K., Sakurai, Y., Okano, T., 1998, Visualization of PEOPBLA-pyrene polymeric micelles by atomic force microscopy. Pharm. Res. 15: 1721-1726.
60. Lavasanifar, A., Samuel, J., Kwon, G. S., 2000, Micelles of poly(ethylene oxide)-block-poly(N-alkyl stearate L-aspartamide): synthetic analogues of lipoproteins for drug delivery. J. Biomed. Mater. Res. 52: 831-835.
61. Lavasanifar, A., Samuel, J., Kwon, G. S., 2001, The effect of alkyl core structure on micellar properties of poly(ethylene glycol)-block-poly(L-aspartamide) derivatives. Colloids and Surfaces B: Biointerfaces 22: 115-126.
62. Yokoyama, M., Satoh, A., Sakurai, Y., Okano, T., Matsumura, Y., Kakizoe, T., Kataoka, K., 1998, Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J. Contr. Rel. 55: 219-229.
63. Aoyagi, T., Sugi, K., Sakurai, Y., Okano, T., Kataoka, K., 1999, Peptide drug carrier: studies on incorporation of vasopressin into nano-associates comprising poly(ethylene glycol)-poly(L-aspartic acid) block copolymer. Colloids and Surface B: Biointerfaces 16: 237-242.
64. Parr, M. J., Masin, D., Cullis, P. R., Bally, M. B., 1997, Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: The lack of beneficial effects by coating liposomes with poly(ethylene glycol). J. Phamacol. Exp. Ther. 280: 1319-1327.
65. Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., Langer, R., 1994, Biodegradable long-circulating polymeric nanospheres. Science 263: 1600-1603.
66. Jeong, Y.-I., Cheon, J.-B., Kim, S.-H., Nah, J.-W., Lee, Y.-M., Sung, Y.-K., Akaike, T., Cho, C.-S., 1998, Clonazepam release from core-shell type nanoparticles in vitro. J. Contr. Rel. 51: 169-178.
67. Burt, H. M., Zhang, X., Toleikis, P., Embree, L., Hunter, W. L., 1999, Development of copolymers of poly(D,L-lactide) and methoxypolyethylele glycol as micellar carriers of paclitaxel. Colloids and Surfaces B: Biointerfaces 16: 161-171.
68. Rosenberg, B., 1978, Platinum complexes for the treatment of cancer. Interdisciplinary Science Reviews 3: 134-147.
69. Ponzani, V., Bressolle, F., Haug, I. J., Galtier, M., Blayac, J. P., 1994, Cisplatin-induced renal toxicity and toxicity-modulating strategies: review. Cancer Chemother. Pharmacol. 35: 1-9.
70. Siddik, Z. H., Newell, D. R., Boxall, F. E., Harrap, K. R., 1987, The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats. Biochemical Pharmacology 36: 1925-1932.
71. Korst, A. C. E., Boven, E., van der Sterre, M. L. T., Fichtinger-Schepman, A. M. J., van der Vijgh, W. J. F., 1998, Pharmacokinetics of cisplatin with and without amifostine in tumour-bearing nude mice. Eur. J. Cancer 34: 412-416.
72. Newman, M. S., Colbern, G. T., Working, P. K., Engbers, C., Amantea, M. A., 1999, Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long circulating, pegylated liposomes (SPI-077) in tumor-bearing mice. Cancer Chemother. Pharmacol. 43:1-7.
73. Avichechter, D., Schechter, B., Arnon, R., 1998, Functional polymers in drug delivery: carrier-supported CDDP (cis-platin) complexes of polycarboxylates - effect on human ovarian carcinoma. React. Funct. Polym. 36: 59-69.
74. Bogdanov Jr., A, Wright, S. C., Marecos, E. M., Bogdanova, A., Martin, C., Petherick, P., Weissleder, R., 1997, A long-circulating co-polymer in "passive targeting" to solid tumors. J. Drug Targeting 4: 321-330.
75. Perez-Soler, R., Han, I., Al-Baker, S., Khokhar, A. R., 1994, Lipophilic platinum complexes entrapped in liposomes: improved stability and preserved antitumor activity with complexes containing linear alkyl carboxylate leaving groups. Cancer Chemother. Pharmacol. 33: 378-384.
76. Ohya, Y., Masunaga, T., Baba, T., Ouchi, T., 1996, Synthesis and cytotoxic activity of dextran carrying cis-dichloro(cyclohexane-trans-1-1,2-diamine) platinum(II) complex. J. Biomater. Sci. Polymer Edn. 7: 1085-1096.
77. Ferruti, P., Ranucci, E., Trotta, F., Gianasi, E., Evagorou, E. G., Wasil, M., Wilson, G., Duncan, R., 1999, Synthesis, characterization, and antitumor activity of platinum(II) complexes of novel functionalised poly(amido amine)s. Macromol. Chem. Phys. 200:1644-1654.
78. Gianasi, E., Wasil, M., Evagarou, E. G., Keddle, A., Wilson, G., Duncan, R., 1999, HPMA copolymer platinates as novel antitumor agents: in vitro properties, pharmacokinetics and antitumor activity in vivo. Eur. J. Cancer 35: 994-1002.
79. Howe-Grant, M. E.; Lippard, S. J., 1980, Aqueous platinum(II) chemistry: Binding to Biological Molecules (chapter 2 in Metal Ions in Biological Systems), Mercel Dekker, New York, NY, 11: 63-125.
80. Schechter, B., Newmann, A., Wilchek, M., Arnon, R., 1989, Soluble polymers as carriers of cis-platinum. J. Contr. Rel. 10: 75-87.
81. Yokoyama, M., Okano, T., Sakurai, Y., Suwa, S., Kataoka, K., 1996, Introduction of cisplatin into polymeric micelle. J. Contr. Rel. 39: 351-356.
82. Nishiyama, N., Yokoyama, M., Aoyagi, T., Okano, T., Sakurai, Y., Kataoka, K., 1999, Preparation and characterization of self-assembled polymer-metal complex micelle from cis-dichlorodiammineplatinum(II) and poly(ethylene glycol)-poly(aspartic acid) block copolymer in an aqueous medium. Langmuir 15: 377-383.
83. Nishiyama, N., Kato, Y., Sugiyama, Y., Kataoka, K., 2001, Development of cisplatin-loaded polymeric micelles with a prolonged circulation in the bloodstream and an enhanced accumulation in the solid tumor. Proceedings of the 20th International Symposium on Controlled Release of Bioactive Compounds 28: 5155-5156.
84. nd International Symposium on Tumor Targeted Delivery Systems
85. Harada, A., Kataoka, K., 1995, Formation of polyion complex micelles in aqueous milieu from a pair of oppositely-charged block copolymers with poly(ethylene glycol) segments. Macromolecules 28: 5294-5299.
86. Harada, A., Kataoka, K., 1999, Chain length recognition: core-shell supermolecular assembly from oppositely charged block copolymers. Science 283: 65-67.
87. Wolfert, M. A., Schacht, E. H., Toncheva, V., Ulbrich, K., Nazarova, O., Seymour, L. W., 1996, Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers. Hum. Gene Ther. 7: 2123-2133.
88. Katayose, S., Kataoka, K., 1997, Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. Bioconj. Chem. 8: 702-707.
89. Kabanov, A. V., Vinogradov, S. V., Suzdaltseva, Y. G., Alakhov, V. Y., 1995, Water-soluble block polycations as carriers for oligonucleotide delivery. Bioconj. Chem. 6: 639-643.
90. Kataoka, K., Togawa, H., Harada, A., Yasugi, K., Matsumoto, T., Katayose, S., 1996, Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline. Macromolecules 29: 8556-8557.
91. Harada, A., Kataoka, K., 1998, Novel polyion complex micelles entrapping enzyme molecules in the core: preparation of narrowly-distributed micelles from lysozyme and poly(ethylene glycol)-poly(aspartic acid) block copolymer in aqueous medium. Macromolecules 31: 4208-4212.
92. Harada, A., Kataoka, K., 1999, On-off control of enzymatic activity synchronizing with reversible formation of supramolecular assembly from enzyme and charged block copolymers. J. Am. Chem. Soc. 121: 9241-9242.
93. Kakizawa, Y., Kataoka, K., 2002, Block copolymer micelles for delivery of gene and related compounds. Adv. Drug Deliv. Rev. 54: 203-222.
94. Macdonald, I. J., Dougherty, T. J., 2001, Basic principles of photodynamic thrapy. J. Porphyrins Phthalocyanines 5: 105-129.
95. 6 and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts. J. Contr. Rel. 61: 145-157.
96. 6-OV-TL 16 antibody immunoconjugates. J. Contr. Rel. 74: 249-253.
97. Fisher, A. M. R., Murphree, A. L., Gomer, C. J., 1995, Clinical and preclinical photodynamic therapy. Lasers in Surgery and Medicine 17: 2-31.
98. Sadamoto, R., Tomioka, N., Aida, T., 1996, Photoinduced electron transfer reaction through dendrimer architecture. J. Am. Chem. Soc. 118: 3978-3979.
99. Jiang D.-L., Aida, T., 1998, Morphology-dependent photochemical events in aryl ether dendrimer porphyrins: cooperation of dendron subunits for singlet energy transduction. J. Am. Chem. Soc. 120: 10895-10901.
100. Nishiyama, N., Stapert, H. R., Zhang, G.-D., Takasu, D., Jiang, D.-L., Nagano, T., Aida, T., Kataoka, K., Light-harvesting dendrimer porphyrins as new photosensitizers for photodynamic therapy, Bioconj. Chem. In press.
101. Stapert, H. R., Nishiyama, N., Kataoka, K., Jiang, D.-L., Aida, T., 2000, Poly-ion complex micelles encapsulating light-harvesting dendrimer porphyrins. Langmuir 16: 8182-8188.
102. Mendelsohn, J., Baselga, J., 2000, The EGF receptor family as targets for cancer therapy. Oncogene 19: 6550-6565.
103. Sebti, S. M., Hamilton, A. D., 2000, Farnesyltransfetase and geranylgeranyltransferase I inhibitors and cancer therapy: Lessons from mechanism and bench-to-bedside translational studies. Oncogene 19: 6584-6593.
104. Sebolt-Leopold, J. S., 2000, Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 19: 6594-6599.
105. Pestell, K. E., Ducruet, A. P., Wipf, P., Lazo, J. S., 2000, Small molecule inhibitors of dual specificity protein phosphatases. Oncogene 19: 6607-6612.
106. Senderowicz, A. M., Small molecule modulators of cyclin-dependent kinases for cancer therapy. Oncogene 19: 6600-6606.
107. Blagosklonny, M. V., 2002, Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs. Leukemia 16: 455-462.
108. Kasuya, Y., Lu, Z.-R., Kopeckova, P., Tabibi, S. E., Kopecek, J., 2002, Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates. Pharm. Res. 19: 115-123.
109. Kasuya, Y., Lu, Z.-R., Kopeckova, P., Minko, T., Tabibi, S.-E., Kopecek, J., 2001, Synthesis and characterization of HPMA copolymer-geldanamycin derivative conjugates. J. Contr. Rel. 74: 203-211.